Caxton Associates LP Amarin Corp Plcuk Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.49 $484 - $645	433 Added 0.45%	96,102 $114,000
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $46,675 - $58,453	43,622 Added 83.81%	95,669 $115,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $177,376 - $271,760	-162,731 Reduced 75.77%	52,047 $57,000
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $242,699 - $792,530	214,778 New	214,778 $320,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.